Toward fully algorithmic care for type 1 diabetes: The case for AI autonomy, and a recalibrated role for the diabetologist in an ageing type 2 diabetes population.
Where this comes from
- Record sourced from PubMed, PMID 42758745.
- Also identified by DOI 10.1371/journal.pdig.0001734.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Artificial intelligence can already automate selected diabetes tasks, but the evidence is uneven. Automated insulin delivery is established in type 1 diabetes; in type 2 diabetes, validated screening and insulin-adjustment tools support a tiered, human-governed model rather than wholesale autonomy.